Internal radiotherapy is an effective method of treatment for metastatic prostate cancer
By Lotta Mitro
The study involved 62 patients who had been treated with 177Lu-PSMA-617 radiopharmaceuticals at Docrates between 2017 and 2019. The study showed that a 4-week treatment interval is safe for patients and leads to good outcomes. Nearly 60% of the patients in the study had a significant decrease in PSA of more than 50 percentage points. … Continued